MedDataX Logo

Lithium Dilution Method in Guiding Fluid Therapy in Critically Ill Patients

NCT ID: NCT00626756

Last Updated: 2008-02-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hypothesis: Fluid management guided by LiDCO doesn´t increase cumulative fluid balance and shorten organ dysfunction compared to fluid management based on CVP and clinical judgment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Illness

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

fluid Lidco technology guided therapy fluid management guided by Lidco technology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LI

arm controled by LIDCO technology

Group Type EXPERIMENTAL

LiDCO technology

Intervention Type DEVICE

non invasive monitoring of cardiac output

CA

standard approach

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LiDCO technology

non invasive monitoring of cardiac output

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age
* Needs for fluid chalange
* Invasive ventilatory supportinvasive blood pressure monitoring
* Lidco monitoring
* Central venous catheter

Exclusion Criteria

* DNR
* Need for CRRT
* Head injury
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ASQA a.s.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

ASQA a.s.

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vladimir Cerny, MD, PhD, FCCM

Role: PRINCIPAL_INVESTIGATOR

University Hospital Hradec Kralove

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

ASQA a.s.

Prague, , Czechia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Czechia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Vladimir Cerny, MD

Role: CONTACT

Email: [email protected]

Pavel Valek, MD

Role: CONTACT

Phone: +420272761350

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Pavel Valek, MD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Sinclair S, James S, Singer M. Intraoperative intravascular volume optimisation and length of hospital stay after repair of proximal femoral fracture: randomised controlled trial. BMJ. 1997 Oct 11;315(7113):909-12. doi: 10.1136/bmj.315.7113.909.

Reference Type BACKGROUND
PMID: 9361539 (View on PubMed)

Wakeling HG, McFall MR, Jenkins CS, Woods WG, Miles WF, Barclay GR, Fleming SC. Intraoperative oesophageal Doppler guided fluid management shortens postoperative hospital stay after major bowel surgery. Br J Anaesth. 2005 Nov;95(5):634-42. doi: 10.1093/bja/aei223. Epub 2005 Sep 9.

Reference Type BACKGROUND
PMID: 16155038 (View on PubMed)

Price J, Sear J, Venn R. Perioperative fluid volume optimization following proximal femoral fracture. Cochrane Database Syst Rev. 2002;(1):CD003004. doi: 10.1002/14651858.CD003004.

Reference Type BACKGROUND
PMID: 11869649 (View on PubMed)

Price JD, Sear JW, Venn RM. Perioperative fluid volume optimization following proximal femoral fracture. Cochrane Database Syst Rev. 2004;(1):CD003004. doi: 10.1002/14651858.CD003004.pub2.

Reference Type BACKGROUND
PMID: 14974001 (View on PubMed)

Conway DH, Mayall R, Abdul-Latif MS, Gilligan S, Tackaberry C. Randomised controlled trial investigating the influence of intravenous fluid titration using oesophageal Doppler monitoring during bowel surgery. Anaesthesia. 2002 Sep;57(9):845-9. doi: 10.1046/j.1365-2044.2002.02708.x.

Reference Type BACKGROUND
PMID: 12190747 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LIGA2008

Identifier Type: -

Identifier Source: secondary_id

LigaStudy

Identifier Type: -

Identifier Source: org_study_id